EGFR Tyrosine Kinase Inhibitor Therapy

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** The use of EGFR tyrosine kinase inhibitors to disrupt the activation of EGFR, effectively halting the signaling cascade for cell growth, thereby decreasing tumor proliferation and migration.